Susan S. Jick, DSc

Professor, Epidemiology
Susan Jick
(781) 862-6660sjick@bu.edu
Talbot – T518E
View full profile at BUMC

Biography

Dr. Susan Jick has been in the field of pharmacoepidemiology for over 25 years working with the Boston Collaborative Drug Surveillance Program where she has conducted research in many areas of drug safety. She has been involved with the use and development of large automated databases including the General Practice Research Database which has become a major resource for conducting drug safety studies and has changed the way these studies are being conducted today. Her research activities range from the safety of drugs such as oral contraceptives in relation to venous thrombosis, hormone replacement therapy in relation to cancers, antibiotics in relation to various serious health outcomes, and statins in relation to autoimmune diseases and diabetes, to safety of drug use in the first trimester of pregnancy and use of folic acid to prevent neural tube defects. Dr Jick helps to run a workshop on methods in conducting drug safety studies that is held each year, she teaches the drug epidemiology class at BUSPH and she serves as an advisor to doctoral students in epidemiology.

Education

  • Carleton College, BA
  • Boston University, MPH
  • Boston University, DSc

Publications

  • Published on 7/1/2014

    Mulder B, Schuiling-Veninga CC, Bos HJ, De Vries TW, Jick SS, Hak E. Response to the comment on: Prenatal exposure to acid-suppressive drugs and the risk of allergic disease in the offspring: a cohort study. Clin Exp Allergy. 2014 Jul; 44(7):1005.

    Read at: PubMed
  • Published on 5/29/2014

    Reinau D, Surber C, Jick SS, Meier CR. Epidemiology of basal cell carcinoma in the United Kingdom: incidence, lifestyle factors, and comorbidities. Br J Cancer. 2014 Jul 1; 111(1):203-6.

    Read at: PubMed
  • Published on 4/1/2014

    Spoendlin J, Bichsel F, Voegel JJ, Jick SS, Meier CR. The association between psychiatric diseases, psychotropic drugs and the risk of incident rosacea. Br J Dermatol. 2014 Apr; 170(4):878-83.

    Read at: PubMed
  • Published on 2/1/2014

    Mulder B, Schuiling-Veninga CC, Bos HJ, De Vries TW, Jick SS, Hak E. Prenatal exposure to acid-suppressive drugs and the risk of allergic diseases in the offspring: a cohort study. Clin Exp Allergy. 2014 Feb; 44(2):261-9.

    Read at: PubMed
  • Published on 1/1/2014

    Bruderer S, Bodmer M, Jick SS, Meier CR. Use of diuretics and risk of incident gout: a population-based case-control study. Arthritis Rheumatol. 2014 Jan; 66(1):185-96.

    Read at: PubMed
  • Published on 1/1/2014

    Layton JB, Li D, Meier CR, Sharpless JL, Stürmer T, Jick SS, Brookhart MA. Testosterone lab testing and initiation in the United kingdom and the United States, 2000 to 2011. J Clin Endocrinol Metab. 2014 Mar; 99(3):835-42.

    Read at: PubMed
  • Published on 11/1/2013

    Hak E, Mulder B, Schuiling-Veninga CC, de Vries TW, Jick SS. Use of acid-suppressive drugs in pregnancy and the risk of childhood asthma: bidirectional crossover study using the general practice research database. Drug Saf. 2013 Nov; 36(11):1097-104.

    Read at: PubMed
  • Published on 10/29/2013

    Jick SS. Drospirenone-containing oral contraceptives may increase the risk of venous thromboembolism. Evid Based Nurs. 2014 Jul; 17(3):71.

    Read at: PubMed
  • Published on 9/24/2013

    Ehrenstein V, Hernandez RK, Ulrichsen SP, Rungby J, Lash TL, Riis AH, Li L, Sørensen HT, Jick SS. Rosiglitazone use and post-discontinuation glycaemic control in two European countries, 2000-2010. BMJ Open. 2013; 3(9):e003424.

    Read at: PubMed
  • Published on 8/28/2013

    Schneider C, Adamcova M, Jick SS, Schlagenhauf P, Miller MK, Rhein HG, Meier CR. Use of anti-malarial drugs and the risk of developing eye disorders. Travel Med Infect Dis. 2014 Jan-Feb; 12(1):40-7.

    Read at: PubMed

View 169 more publications:View full profile at BUMC